Kate Park / TechCrunch:

Boston- and Tel Aviv-based Converge Bio, which uses AI trained on molecular data to help pharma and biotech companies develop drugs, raised a $25M Series A  —  Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways …

Kate Park / TechCrunch:

Boston- and Tel Aviv-based Converge Bio, which uses AI trained on molecular data to help pharma and biotech companies develop drugs, raised a $25M Series A  —  Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways …

Source: TechMeme
Source Link: http://www.techmeme.com/260113/p14#a260113p14